D-dimer as a prognostic tool in patients with normotensive pulmonary embolism

Tuberculosis and Respiratory Diseases

Volumn 68, Issue 2, 2010, Pages 87-92

  Yoon, Jae Choi ^b   Kim, Won Young ^a   Choi, Sang Sik ^a   Jung, Sang Ku ^a   Sohn, Chang Hwan ^a   Kim, Won ^a   Lim, Kyoung Soo ^a   Jeong, Tae O ^b   Jin, Young Ho ^b   Lee, Jae Baek ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

Blood pressure, normal; Fibrin fibrinogen degradation products; Prognosis; Pulmonary embolism

Indexed keywords

D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; LUNG EMBOLISM; MALE; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT;

EID: 77949634229     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2010.68.2.87     Document Type: Article

References (22)

1. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part II: risk stratification, treatment, and prevention. Circulation 2003;108:2834-8.
2. Kreit JW. The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest 2004;125:1539-45.
3. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005;172:1041-6.
4. Punukollu G, Gowda RM, Vasavada BC, Khan IA. Role of electrocardiography in identifying right ventricular dysfunction in acute pulmonary embolism. Am J Cardiol 2005;96:450-2.
5. Logeart D, Lecuyer L, Thabut G, Tabet JY, Tartiere JM, Chavelas C, et al. Biomarker-based strategy for screening right ventricular dysfunction in patients with non-massive pulmonary embolism. Intensive Care Med 2007;33:286-92.
6. Schoepf UJ, Kucher N, Kipfmueller F, Quiroz R, Costello P, Goldhaber SZ. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 2004;110:3276-80.
7. Ghanima W, Abdelnoor M, Holmen LO, Nielssen BE, Ross S, Sandset PM. D-dimer level is associated with the extent of pulmonary embolism. Thromb Res 2006;120:281-8.
8. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 2002;347:1143-50.
9. Galle C, Papazyan JP, Miron MJ, Slosman D, Bounameaux H, Perrier A. Prediction of pulmonary embolism extent by clinical findings, D-dimer level and deep vein thrombosis shown by ultrasound. Thromb Haemost 2001;86:1156-60.
10. Klok FA, Djurabi RK, Nijkeuter M, Eikenboom HC, Leebeek FW, Kramer MH, et al. High D-dimer level is associated with increased 15-d and 3 months mortality through a more central localization of pulmonary emboli and serious comorbidity. Br J Haematol 2008;140:218-22.
11. Blamoun J, Alfakir M, Sedfawy AI, Moammar MQ, Maroules M, Khan MA, et al. The association of D-dimer levels with clinical outcomes in patients presenting with acute pulmonary embolism. Lab Hematol 2009;15:4-9.
12. Lobo JL, Zorrilla V, Aizpuru F, Grau E, Jimenez D, Palareti G, et al. D-dimer levels and 15-day outcome in acute pulmonary embolism Findings from the RIETE registry. J Thromb Haemost 2009;7:1795-801.
13. Grau E, Tenias JM, Soto MJ, Gutierrez MR, Lecumberri R, Perez JL, et al. D-dimer levels correlate with mortality in patients with acute pulmonary embolism: findings from the RIETE registry. Crit Care Med 2007;35:1937-41.
14. Kabbara R, Labarere J, Pernod G, Bosson JL. D-dimer level is not a prognostic biomarker specific of pulmonary embolism. Crit Care Med 2008;36:652-3; author reply 653.
15. Bova C, Pesavento R, Marchiori A, Palla A, Enea I, Pengo V, et al. Risk stratification and outcomes in hemodynamically stable patients with acute pulmonary embolism: a prospective, multicentre, cohort study with three months of follow-up. J Thromb Haemost 2009;7:938-44.
16. Söhne M, Ten Wolde M, Büller HR. Biomarkers in pulmonary embolism. Curr Opin Cardiol 2004;19:558-62.
17. Aujesky D, Roy PM, Guy M, Cornuz J, Sanchez O, Perrier A. Prognostic value of D-dimer in patients with pulmonary embolism. Thromb Haemost 2006;96:478-82.
18. Agterof MJ, van Bladel ER, Schutgens RE, Snijder RJ, Tromp EA, Prins MH, et al. Risk stratification of patients with pulmonary embolism based on pulse rate and D-dimer concentration. Thromb Haemost 2009;102:683-7.
19. Vuilleumier N, Le Gal G, Verschuren F, Perrier A, Bounameaux H, Turck N, et al. Cardiac biomarkers for risk stratification in non-massive pulmonary embolism: a multicenter prospective study. J Thromb Haemost 2009;7:391-8.
20. Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 2003;107:2545-7.
21. Kline JA, Zeitouni R, Marchick MR, Hernandez-Nino J, Rose GA. Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism. Am Heart J 2008;156:308-14.
22. Vuilleumier N, Righini M, Perrier A, Rosset A, Turck N, Sanchez JC, et al. Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism. Thromb Res 2007;121:617-24.